Verona Pharma plc VRNA
Set alert
106.91 0.00 0.00%
At close · Oct 7
106.91 Day range 106.91
31.60 52-week range 106.93
- YTD
- +130.21%
- 1 year
- +233.99%
- Open
- 106.91
- Prev close
- 106.91
- Mkt cap
- 9.09B
- Vol
- 1.87M
- Avg vol
- 1.69M
- EPS
- -1.04
- P/E
- 872.73
- Div yield
- 0.00%
More statistics
- Low
- 106.91
- High
- 106.91
- Forward P/E
- -381.82
- Beta
- 0.05
- Short ratio
- 1.56
- Inst. own
- 92.23%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 3, 2025
- 50-d avg
- 105.95
- 200-d avg
- 79.84
- 1y target
- 0.00
Ownership
Held by insiders 4.89%
Held by institutions 92.23%
Float held by institutions 96.97%
Institutions 374
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Janus Henderson Group PLC | 7.12% | 6,134,405 | 655.83M | Jun 29, 2025 |
| Perceptive Advisors Llc | 6.39% | 5,507,591 | 588.82M | Jun 29, 2025 |
| Darwin Global Management, Ltd. | 4.79% | 4,129,618 | 441.50M | Jun 29, 2025 |
| Frazier Life Sciences Management, L.P. | 3.93% | 3,383,950 | 361.78M | Jun 29, 2025 |
| RTW Investments LP | 3.54% | 3,051,878 | 326.28M | Jun 29, 2025 |
| Eventide Asset Management LLC | 3.15% | 2,715,324 | 290.30M | Jun 29, 2025 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| MUTUAL FUND SERIES TRUST-Eventide Gilead Fund | 2.19% | 1,889,627 | 202.02M | Jun 29, 2025 |
| T. Rowe Price Health Sciences Fund, Inc. | 1.57% | 1,357,044 | 145.08M | Jun 29, 2025 |
| JANUS INVESTMENT FUND-Janus Henderson Global Life Sciences Fund | 1.09% | 936,802 | 100.15M | Jun 29, 2025 |
| Manager Directed Portfolios-Hood River Small-Cap Growth Fund | 0.95% | 820,644 | 87.74M | Jul 30, 2025 |
| MUTUAL FUND SERIES TRUST-Eventide Healthcare & Life Sciences Fund | 0.94% | 809,112 | 86.50M | Jun 29, 2025 |
| Putnam Funds Trust-Putnam Small Cap Growth Fund | 0.85% | 734,132 | 78.49M | Jun 29, 2025 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ACKERMANN CHRISTINA M | Director | Conversion of Exercise of derivative security | Oct 6, 2025 | 0 |
| AUSTWICK MICHAEL | Director | Conversion of Exercise of derivative security | Oct 6, 2025 | 0 |
| DESCHAMPS LISA | Director | Conversion of Exercise of derivative security | Oct 6, 2025 | 0 |
| EDWARDS MARTIN | Director | Conversion of Exercise of derivative security | Oct 6, 2025 | 0 |
| HAHN MARK W | Chief Financial Officer | Conversion of Exercise of derivative security | Oct 6, 2025 | 0 |
| RICKARD KATHLEEN A | Officer | Conversion of Exercise of derivative security | Oct 6, 2025 | 0 |